维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

18篇 您的检索式：作者名="Moosmann S"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	“En bloc ” caudate lobe and inferior vena cava resection following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal and liver metastasis of colorectal cancer显示文摘There are diverse protocols to manage patients with recurrent disease after primary cytoreductive surgery(CRS) with hyperthermic intraperitoneal chemotherapy(HIPEC) for peritoneal carcinomatosis. We describe a case of metachronous liver metastasis after CRS and HIPEC for colorectal cancer, successfully treated with a selective metastectomy and partial graft of the inferior vena cava. A 35-year-old female presented with a large tumour in the cecum and consequent colonic stenosis. After an emergency right colectomy, the patient received adjuvant chemotherapy. One year later she was diagnosed with peritoneal carcinomatosis, and it was decided to carry out a CRS/HIPEC. After 2 years of total remission, an isolated metachronous liver metastasis was detected by magnetic resonance imaging surveillance. The patient underwent a third procedure including a caudate lobe and partial inferior vena cava resection with a prosthetic graft interposition, achieving an R0 situation. The postoperative course was uneventful and the patient was discharged on postoperative day 17 after the liver resection. At 18-mo follow-up after the liver resection the patient remained free of recurrence. In selected patients, the option of re-operation due to recurrent disease should be discussed. Even liver resection of a metachronous metastasis and an extended vascular resection are acceptable after CRS/HIPEC and can be considered as a potential treatment option to remove all macroscopic lesions.	Patricia Sánchez-Velázquez Nicolas Moosmann Ingolf T?pel Pompiliu Piso	2016	World Journal of Gastroenterology2016，22，46：	3
	2	The EBV and BNLF2a protect newly infected B cells from immune recognition and elimination 显示文摘	Jochum S Moosmann A Lang S	2012	PLoS Pathog2012，8，10：	1
	3	The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination 显示文摘	Jochum S Moosmann A Lang S	2012	PLoS Pathog2012，8，10：	1
	4	The treatment of colorectal carcinoma with monoclonal antibodies: the importance of KRAS mutation analysis and EGFR status 显示文摘	Stlntzing S Heinemann V Moosmann N	2009	Dtsch Arztebl Int2009，106，12：	1
	5	The treatment of colorectal ear-ci noma with monoclonal antibodies:the importance of KRAS mutation analysis and EGFR status显示文摘	Stintzing S Heinemann V Moosmann N	2009	Dtsch Arztebl Int2009，106，12：	1
	6	Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis ofprimary human B cells 显示文摘	Seto E Moosmann A Gromminger S	2010	PLoS Pathog2010，6，00：	1
	7	Milieu-adopted in vitro and in vivo differentiation of mesenchymal tis- sues derived from different adult human CD34-negative progenitor eeU clones显示文摘	Moosmann S Hutter J Moser C	2005	Cells Tissues Organs2005，179，3：	1
	8	Mesenchymal differentiation and organ distribution of established human stromal cell lines in NOD/SCID mice显示文摘	Thalmeier K Meissner P Moosmann S	2001	Acta Haematol2001，105，3：	1
	9	The treatment of colorectal carcinoma with monoclonal antibodies: the importance of KRAS mutation analysis and EGFR status 显示文摘	Stintzing S Heinemann V Moosmann N	2009	Deutsches Arzteblatt Int2009，106，12：	1
	10	The EBV immunoevasins v IL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination显示文摘	Jochum S Moosmann A Lang S	2012	PLo S Pathog2012，8，10：	1
	11	The treatment of colorectal carcinoma with monoclonal antibodies:the importance of KRAS mutation analysis and EGFR status显示文摘	Stintzing S Heinemann V Moosmann N	2009	Dtsch Arztebl Int2009，106，12：	1
	12	Inhibition ofglycogen synthase kinase 3βis involved in the resistance tooxidative stress in neuronal HT22cells显示文摘	Schfer M Goodenough S Moosmann B	2004	Brain Research2004，1005，12：	1
	13	Mesenchymal differentiation and organ distribution of established human stromal cell lines in NOD/SCID mice显示文摘	Thalmeier K Meissner P Moosmann S	2001	Acta Haematol2001，105，3：	1
	14	The treatment of colorectal carcinoma with monoclonal antibodies: the importance of KRAS mutation analysis and EGFR status显示文摘	Stintzing S Heinemann V Moosmann N	2009	Dtsch Arztebl Int2009，106，：	1
	15	The EBV immunoeva- sins vIL-10 and BNLF2a protect newly infected B cells from im- mune recognition and elimination 显示文摘	Joehum S Moosmann A Laag S	2012	PLoS Pathog2012，8，10：	1
	16	LC/ESI-MS/MS meth- od for quantification of 28 synthetic cannabinoids in neat oral fluid and its application to preliminary studies on their detection windows 显示文摘	Kneisel S Speck M Moosmann B	2013	Anal Bioanal Chem2013，405，14：	1
	17	The EBV immunoevasins vI L-10 and BNLF2a protect newly infected B cells from immune recognition and elimination显示文摘	Jochum S Moosmann A Lang S	2012	PLoS Pathog2012，8，10：	1
	18	Improved arteriogenesis with simultaneous skeletal muscle repair in ischemic tissue by SCL(+)multipotent adult progenitor cell clones from peripheral blood显示文摘	Huss R Heil M Moosmann S	2004	J Vas Res2004，41，5：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费